Practical considerations for choosing a mouse model of Alzheimer’s disease
Abstract Alzheimer’s disease (AD) is behaviorally identified by progressive memory impairment and pathologically characterized by the triad of β-amyloid plaques, neurofibrillary tangles, and neurodegeneration. Genetic mutations and risk factors have been identified that are either causal or modify t...
Main Authors: | Joanna L. Jankowsky, Hui Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-12-01
|
Series: | Molecular Neurodegeneration |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13024-017-0231-7 |
Similar Items
-
Temporal and spatially controlled APP transgene expression using Cre-dependent alleles
by: Emily J. Koller, et al.
Published: (2022-05-01) -
Transgenic APP expression during postnatal development causes persistent locomotor hyperactivity in the adult
by: Rodgers Shaefali P, et al.
Published: (2012-06-01) -
Contribution of GABAergic interneurons to amyloid-β plaque pathology in an APP knock-in mouse model
by: Heather C. Rice, et al.
Published: (2020-01-01) -
Amyloid-β plaque formation and reactive gliosis are required for induction of cognitive deficits in App knock-in mouse models of Alzheimer’s disease
by: Yasufumi Sakakibara, et al.
Published: (2019-03-01) -
Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models
by: Oliver Wirths, et al.
Published: (2020-10-01)